Cargando…
FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration
Radiotherapy is one of the standard treatments for cervical cancer and head and neck cancer. However, the clinical efficacy of this treatment is limited by radioresistance. The discovery of effective prognostic biomarkers and the identification of new therapeutic targets have helped to overcome the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264437/ https://www.ncbi.nlm.nih.gov/pubmed/34249689 http://dx.doi.org/10.3389/fonc.2021.653005 |
_version_ | 1783719556328456192 |
---|---|
author | Li, Sisi Huang, Xiao-ting Wang, Meng-yao Chen, Dong-ping Li, Ming-yi Zhu, Yan-yi Yu, Yi Zheng, Lu Qi, Bin Liu, Jin-quan |
author_facet | Li, Sisi Huang, Xiao-ting Wang, Meng-yao Chen, Dong-ping Li, Ming-yi Zhu, Yan-yi Yu, Yi Zheng, Lu Qi, Bin Liu, Jin-quan |
author_sort | Li, Sisi |
collection | PubMed |
description | Radiotherapy is one of the standard treatments for cervical cancer and head and neck cancer. However, the clinical efficacy of this treatment is limited by radioresistance. The discovery of effective prognostic biomarkers and the identification of new therapeutic targets have helped to overcome the problem of radioresistance. In this study, we show that in the context of PIK3CA mutation or amplification, high expression of fascin actin-bundling protein 1 (FSCN1) (using the median as the cut-off value) is associated with poor prognosis and radiotherapy response in cancer patients. Silencing FSCN1 enhances radiosensitivity and promotes apoptosis in cancer cells with PIK3CA alterations, and this process may be associated with the downregulation of YWHAZ. These results reveal that FSCN1 may be a key regulator of radioresistance and could be a potential target for improving radiotherapy efficacy in cervical cancer and head and neck cancer patients with PIK3CA alterations. |
format | Online Article Text |
id | pubmed-8264437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82644372021-07-09 FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration Li, Sisi Huang, Xiao-ting Wang, Meng-yao Chen, Dong-ping Li, Ming-yi Zhu, Yan-yi Yu, Yi Zheng, Lu Qi, Bin Liu, Jin-quan Front Oncol Oncology Radiotherapy is one of the standard treatments for cervical cancer and head and neck cancer. However, the clinical efficacy of this treatment is limited by radioresistance. The discovery of effective prognostic biomarkers and the identification of new therapeutic targets have helped to overcome the problem of radioresistance. In this study, we show that in the context of PIK3CA mutation or amplification, high expression of fascin actin-bundling protein 1 (FSCN1) (using the median as the cut-off value) is associated with poor prognosis and radiotherapy response in cancer patients. Silencing FSCN1 enhances radiosensitivity and promotes apoptosis in cancer cells with PIK3CA alterations, and this process may be associated with the downregulation of YWHAZ. These results reveal that FSCN1 may be a key regulator of radioresistance and could be a potential target for improving radiotherapy efficacy in cervical cancer and head and neck cancer patients with PIK3CA alterations. Frontiers Media S.A. 2021-06-24 /pmc/articles/PMC8264437/ /pubmed/34249689 http://dx.doi.org/10.3389/fonc.2021.653005 Text en Copyright © 2021 Li, Huang, Wang, Chen, Li, Zhu, Yu, Zheng, Qi and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Li, Sisi Huang, Xiao-ting Wang, Meng-yao Chen, Dong-ping Li, Ming-yi Zhu, Yan-yi Yu, Yi Zheng, Lu Qi, Bin Liu, Jin-quan FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration |
title | FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration |
title_full | FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration |
title_fullStr | FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration |
title_full_unstemmed | FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration |
title_short | FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration |
title_sort | fscn1 promotes radiation resistance in patients with pik3ca gene alteration |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264437/ https://www.ncbi.nlm.nih.gov/pubmed/34249689 http://dx.doi.org/10.3389/fonc.2021.653005 |
work_keys_str_mv | AT lisisi fscn1promotesradiationresistanceinpatientswithpik3cagenealteration AT huangxiaoting fscn1promotesradiationresistanceinpatientswithpik3cagenealteration AT wangmengyao fscn1promotesradiationresistanceinpatientswithpik3cagenealteration AT chendongping fscn1promotesradiationresistanceinpatientswithpik3cagenealteration AT limingyi fscn1promotesradiationresistanceinpatientswithpik3cagenealteration AT zhuyanyi fscn1promotesradiationresistanceinpatientswithpik3cagenealteration AT yuyi fscn1promotesradiationresistanceinpatientswithpik3cagenealteration AT zhenglu fscn1promotesradiationresistanceinpatientswithpik3cagenealteration AT qibin fscn1promotesradiationresistanceinpatientswithpik3cagenealteration AT liujinquan fscn1promotesradiationresistanceinpatientswithpik3cagenealteration |